Sage Therapeutics Statistics
Total Valuation
LON:0LP3 has a market cap or net worth of GBP 28.68 billion. The enterprise value is 30.79 billion.
Market Cap | 28.68B |
Enterprise Value | 30.79B |
Important Dates
The last earnings date was Wednesday, July 30, 2025.
Earnings Date | Jul 30, 2025 |
Ex-Dividend Date | Jun 13, 2025 |
Share Statistics
Current Share Class | 139.71M |
Shares Outstanding | n/a |
Shares Change (YoY) | -2.25% |
Shares Change (QoQ) | -0.43% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 139.49M |
Valuation Ratios
The trailing PE ratio is 42.89 and the forward PE ratio is 37.74.
PE Ratio | 42.89 |
Forward PE | 37.74 |
PS Ratio | 13.16 |
PB Ratio | 125.69 |
P/TBV Ratio | n/a |
P/FCF Ratio | 38.50 |
P/OCF Ratio | 31.67 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 27.66, with an EV/FCF ratio of 41.34.
EV / Earnings | 46.05 |
EV / Sales | 13.66 |
EV / EBITDA | 27.66 |
EV / EBIT | 30.84 |
EV / FCF | 41.34 |
Financial Position
The company has a current ratio of 1.53, with a Debt / Equity ratio of 10.97.
Current Ratio | 1.53 |
Quick Ratio | 1.41 |
Debt / Equity | 10.97 |
Debt / EBITDA | 2.32 |
Debt / FCF | 3.36 |
Interest Coverage | 9.56 |
Financial Efficiency
Return on equity (ROE) is 243.11% and return on invested capital (ROIC) is 22.14%.
Return on Equity (ROE) | 243.11% |
Return on Assets (ROA) | 17.29% |
Return on Invested Capital (ROIC) | 22.14% |
Return on Capital Employed (ROCE) | 33.95% |
Revenue Per Employee | 279,467 |
Profits Per Employee | 85,726 |
Employee Count | 7,800 |
Asset Turnover | 0.62 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, LON:0LP3 has paid 201.16 million in taxes.
Income Tax | 201.16M |
Effective Tax Rate | 23.26% |
Stock Price Statistics
The stock price has increased by +5.34% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +5.34% |
50-Day Moving Average | 305.56 |
200-Day Moving Average | 291.55 |
Relative Strength Index (RSI) | 22.09 |
Average Volume (20 Days) | 91 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, LON:0LP3 had revenue of GBP 2.18 billion and earned 668.66 million in profits. Earnings per share was 4.73.
Revenue | 2.18B |
Gross Profit | 1.51B |
Operating Income | 965.29M |
Pretax Income | 864.71M |
Net Income | 668.66M |
EBITDA | 1.06B |
EBIT | 965.29M |
Earnings Per Share (EPS) | 4.73 |
Balance Sheet
The company has 459.76 million in cash and 2.50 billion in debt, giving a net cash position of -2.04 billion.
Cash & Cash Equivalents | 459.76M |
Total Debt | 2.50B |
Net Cash | -2.04B |
Net Cash Per Share | n/a |
Equity (Book Value) | 228.17M |
Book Value Per Share | 1.63 |
Working Capital | 348.89M |
Cash Flow
In the last 12 months, operating cash flow was 905.66 million and capital expenditures -160.87 million, giving a free cash flow of 744.79 million.
Operating Cash Flow | 905.66M |
Capital Expenditures | -160.87M |
Free Cash Flow | 744.79M |
FCF Per Share | n/a |
Margins
Gross margin is 69.39%, with operating and profit margins of 44.28% and 30.67%.
Gross Margin | 69.39% |
Operating Margin | 44.28% |
Pretax Margin | 39.67% |
Profit Margin | 30.67% |
EBITDA Margin | 48.46% |
EBIT Margin | 44.28% |
FCF Margin | 34.17% |
Dividends & Yields
This stock pays an annual dividend of 1.29, which amounts to a dividend yield of 0.46%.
Dividend Per Share | 1.29 |
Dividend Yield | 0.46% |
Dividend Growth (YoY) | 11.40% |
Years of Dividend Growth | 3 |
Payout Ratio | 27.16% |
Buyback Yield | 2.25% |
Shareholder Yield | 2.72% |
Earnings Yield | 2.33% |
FCF Yield | 2.60% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 7 |